Tami Mark

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

The United States must improve its data infrastructure to ensure high-quality mental health care

CMS Innovation Center Behavioral Health Payment and Care Delivery Innovation Summit

Telehealth a Game Changer for Addiction Treatment?

Risk adjustment for people with chronic conditions in private sector health plans

Medicare Part D Plans Have Removed Barriers to Opioid Use Disorder Medications

A Decade of Data Tracked the Quality of Addiction Treatment Centers Over Time and Across States Using Federal Government’s ‘Signs’ of Higher Quality

Effects of the 2013 psychiatric current procedural rerminology codes revision on psychotherapy in psychiatric billing

Spending for mental health and substance abuse treatment, 1996

New research finds racial disparity in use and access to medications for opioid use disorder

Mental Health and Substance Abuse Treatment Prescription Drugs: Lessons From a Period of High Spending Growth

The effects of prescription drug copayments on statin adherence

Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty

Psychiatric hospital ownership and performance: Do nonprofit organizations offer advantages in markets characterized by asymmetric information?

Buprenorphine prescribing for Medicaid beneficiaries down in 2020

The costs of treating persons with depression and alcoholism compared with depression alone

For What Diagnoses Are Psychiatric Medications Being Prescribed

The return on investment of postdischarge follow-up calls for suicidal ideation or deliberate self-harm

Measurement: The Missing Link to Quality Addiction Treatment

Understanding US addiction physicians' low rate of naltrexone prescription

CMS Policy Change Improved Addiction Treatment Access